2026 Q2 Form 10-Q
Open PDF
| Stock | Imricor Medical Systems Inc (IMR.ASX) |
|---|---|
| Release Time | 10 Aug 2026, 8:39 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Imricor Medical Systems Q2 2026 Financial Results
Key Points
- Net loss of $7.4 million for Q2 2026
- Total revenue for Q2 2026 was $60.5 million
- Cash and cash equivalents increased to $60.5 million
Full Summary
Imricor Medical Systems, Inc. reported its financial results for the second quarter of 2026. The company reported a net loss of $7.4 million for the quarter, compared to a net loss of $5.7 million in the same period last year. Total revenue for Q2 2026 was $60.5 million, down from $65.2 million in Q2 2025. The company's cash and cash equivalents increased to $60.5 million as of June 30, 2026, from $19.5 million as of December 31, 2025. The company's total assets stood at $73.6 million as of June 30, 2026, compared to $45.8 million as of December 31, 2025.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In